Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of NCR300 in Preventing Recurrence of Acute Myeloid Leukemia（AML) After Transplantation [Phase 1]

View source ↗

Summary

A Phase 1 trial update evaluating the safety and efficacy of NCR300 to prevent recurrence of acute myeloid leukemia after transplantation; the study status is n…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• NCR300

Snippet

Sponsor: Nuwacell Biotechnologies Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: NOT_YET_RECRUITING